Developers of biosimilars -- medicines that are near-identical copies of biologic drugs -- will no longer be required to conduct clinical trials to prove effectiveness.

Shortages to backbone chemotherapy drugs are negatively affecting patient care, and more shortages are likely without policy ...

October 2025 proved to be a significant month for the oncology landscape, marked by a wave of key regulatory decisions from the US FDA. This period saw important full and accelerated drug approvals ...

More than 580,000 bottles of a popular blood pressure medication distributed nationwide have been recalled, according to the U.S. Food and Drug Administration. The recall involves bottles of Prazosin ...

According to the FDA, the Centers for Disease Control and Prevention's case count for illnesses tied to the listeria outbreak has increased, with seven reports of new illnesses across three states, ...

The US Food and Drug Administration said Friday that it is taking action to restrict the use of prescription fluoride supplements, following a directive from the government’s Make American Healthy ...

The Food and Drug Administration (FDA) has put four companies on notice for marketing “unapproved fluoride-containing ingestible drugs” for use by children under the age of 3 or children at low or ...

The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some ...

Teva Pharmaceuticals USA and drug distributor Amerisource Health Services has recalled more than half a million bottles of a ...

Over half a million bottles of prazosin hydrochloride have been recalled for having high levels of potentially cancer-causing ...

Blood pressure medication was recalled by the FDA. The prescription drug didn’t meet the agency’s standards for a lack of ...